Michael Soulen, MD of Hospital of the University of Pennsylvania gives an update on the RETNET Trial or the Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver from ASCO GI 2017
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver
